baber/WOPTO huggingface dataset:
Patent AU-2021203696-A1 (AU)
Title: Monitoring Device
Inventor: LYSTER JARRAD CLAYTON
IPC: E21D21/02
Filed: 2021-06-04
Abstract: zo 
ABSTRACT 
An indication means for monitoring a stabilisation apparatus inserted in a rock 
formation, the indication means comprising a body adapted to provide an indication of 
the status of the stabilisation apparatus providing support to the rock formation, wherein 
the body is operatively associated with the stabilisation apparatus such that upon 
variation in the quality of support provided by the stabilisation apparatus to the rock 
formation, the indications means provide an indication that the variation in the quality of 
the support provided by the stabilisation apparatus has occurred. There is also provided 
a monitoring device for monitoring a stabilisation apparatus inserted in a rock formation, 
the monitoring device comprising the indication means and means for operatively 
associating the indication means with the stabilisation apparatus, and the stabilisation 
apparatus comprising the monitoring device.  
Fig 23
570 
rF@ 23
Patent AU-2021203899-A1 (AU)
Title: Transcatheter valve prosthesis and method for implanting the same
Inventor: NASR MALEK
IPC: A61F2/24
Filed: 2021-06-11
Abstract: A transcatheter valve prosthesis and a method for implanting the prosthesis in a heart 
are disclosed. The prosthesis includes a tubular body a coupled to a prosthetic valve. A 
fabric may be disposed on an outer surface of the tubular body. The method includes 
partially deploying the tubular body from a catheter to at position distal of a distal edge of a 
native valve leaflet, and moving the catheter such that the deployed outflow end portion of 
the tubular body engages the distal edge of the native valve leaflet and lifts the native valve 
leaflet in the proximal direction towards an atrial chamber of the heart. Then, the tubular 
body can be fully deployed such that the native valve leaflet is captured between the outflow 
end portion and the inflow end portion.
CD 
C...  
C)6
Patent AU-2021207857-A1 (AU)
Title: Fluid control in microfluidic devices
Inventor: QUINLAN THOMAS J
IPC: G01N33/68
Filed: 2021-01-13
Abstract: A diagnostic system for determining the presence of a target in a sample liquid that includes a diagnostic reader and a microfluidic strip having a microfluidic channel network therein. An actuator within the reader modifies the pressure of a gas in gaseous communication with a liquid-gas interface of a sample liquid within the microfluidic channel network to move and/or mix the sample liquid. The pressure modifications may be continuous and/or oscillatory.
Patent AU-2021209740-A1 (AU)
Title: SEMG2 antibody and use thereof
Inventor: LI ZHAOLI
IPC: A61K39/395
Filed: 2021-01-21
Abstract: Provided is a compound that agonizes or antagonizes the interaction between SEMG2 and CD27, comprising a small molecule inhibitor, a polypeptide, an antibody, or an antigen-binding fragment. The polypeptide is used as an immunogen to prepare an antibody for blocking the binding of SEMG2 and CD27, thereby promoting anti-tumor immunity. Also disclosed is a screening method for screening a therapeutic drug by blocking the binding of SEMG2 and CD27.
Patent AU-2021212051-A1 (AU)
Title: A novel method of producing improved lightweight ceramic sand and uses thereof
Inventor: KHAN ABBAS
IPC: C04B18/02
Filed: 2021-08-05
Abstract: The present invention discloses a novel, improved, simple and economic process for 
manufacturing lightweight ceramic sand. The lightweight ceramic sand is produced from 
the industrial wastes, wherein the major raw materials are fly ash, bauxite residue and 
biomass-coal fly ash. The present invention relates to the production of new fine 
particulates at high throughput and at low manufacturing cost to provide an alternative or 
substitute to the fast-depleting natural sand including crushed stones and lightweight fine 
aggregates produced from expanded clay, expanded glass and volcanic activities.  
Lightweight ceramic sand of the present invention can be used as a building and 
construction material and foundry sand.  
20
Partially dried bauxite residue Granulated material Dried material 
Secondary raw 
materials Conditioning, Sintering 
Fly ___ash_ Mixing and Drying S75-ter25g 
Fly ash Granulation 125-250°C 975-1,225°C 
Bentonite 
Fig. 1 
1600 
1400 1350 
E 1200 
985 
1000 
800 
600 
400 
200 
New ceramic sand (FA Former ceramic sand (FA 
85wt%-BR15wt/o) 15wt%-BR 85wt%) 
Fig. 2 
21
Patent AU-2021216593-A1 (AU)
Title: Compositions and methods for circular RNA expression
Inventor: ASOKAN ARAVIND
IPC: C12N15/11
Filed: 2021-04-01
Abstract: The present disclosure provides nucleic acid molecules encoding for at least two circular RNA (circRNAs), adeno-associated virus (AAV) particles including nucleic acid molecules encoding for at least two circRNAs, pharmaceutical compositions, and methods for delivering such to a subject.
Patent AU-2021221865-A1 (AU)
Title: Photosensitive dispersion and use thereof
Inventor: KÖNIG BURKHARD
IPC: A61K8/04
Filed: 2021-08-26
Abstract: : 
The invention relates to a photosensitizer-containing dispersion and to the use thereof.
Patent AU-2021232720-A1 (AU)
Title: Expandable devices for positioning organs
Inventor: FOJTIK SHAWN P
IPC: A61M29/02
Filed: 2021-09-15
Abstract: EXPANDABLE DEVICES FOR POSITIONING ORGANS 
ABSTRACT 
A positioning device is configured to selectively position or otherwise manipulate one or more 
organs within the body of a subject. The positioning device includes a shaped expandable 
element that is configured to be selectively transitioned between an unexpanded, or collapsed, 
state and an expanded state. While in the expanded state, the expandable element repositions or 
otherwise manipulates an organ. Systems that include positioning devices are also disclosed, as 
are methods for positioning or otherwise manipulating organs.
Patent AU-2021236226-A1 (AU)
Title: Methods and composition for gene delivery using an engineered viral particle
Inventor: GILL SAAR
IPC: C12N15/86
Filed: 2021-03-11
Abstract: The present invention provides compositions and methods for transducing cells (e.g. T cells or immune cells). Also provided herein are methods of treating a disease in a subject in need thereof.
Patent AU-2021246485-A1 (AU)
Title: Immunotheranostic agent targeting mesenchymal stem cell-derived cancer cells and mesenchymal stem cell associated disease
Inventor: ULMERT HANS DAVID
IPC: C07K16/30
Filed: 2021-03-31
Abstract: The present disclosure provides a radiotheranostic agent targeting LRRC15 expressed on cells derived from or associated with mesenchymal stem cells. The LRRC15 targeting agent would significantly improve diagnosis and treatment of a broad range of diseases and malignancies. In one embodiment, the LRRC15 targeting agent is a humanized monoclonal antibody (DUNP19) that has high binding affinity to LRRC15 and is internalized by cells expressing LRRC15.
Patent AU-2021250319-A1 (AU)
Title: Selective GIP receptor agonists comprising a chelating moiety for imaging and therapy purposes
Inventor: EVERS ANDREAS
IPC: C07K14/435
Filed: 2021-03-30
Abstract: The present invention relates to GIP(1-30) analogues which selectively bind and activate the GIP receptor and comprise a chelating moiety capable of binding a metal ion and their use, for example in PET imaging or for radiotherapy.
Patent AU-2021261909-A1 (AU)
Title: Antisense oligomers for treatment of conditions and diseases
Inventor: AZNAREZ ISABEL
IPC: C12Q1/68
Filed: 2021-11-04
Abstract: Alternative splicing events in SCN1A gene can lead to non-productive mRNA transcripts 
which in turn can lead to aberrant protein expression, and therapeutic agents which can 
target the alternative splicing events in SCN1A gene can modulate the expression level of 
functional proteins in Dravet Syndrome patients and/or inhibit aberrant protein 
expression. Such therapeutic agents can be used to treat a condition caused by SCN1A, 
SCN8A or SCN5A protein deficiency.
Patent AU-2021264846-A1 (AU)
Title: TGFβR2 extracellular domain truncated molecule, fusion protein of TGFβR2 extracellular domain truncated molecule and anti-EGFR antibody, and anti-tumor use of fusion protein
Inventor: XIE LIANGZHI
IPC: C07K14/495
Filed: 2021-04-26
Abstract: Provided are multiple types of TGFβR2 in truncated forms and a fusion protein constructed by TGFβR2 and EGFR antibody HPA8; also provided are a nucleic acid (comprising heavy/light chain variable regions) encoding the antibody, and a vector, a pharmaceutical composition, and a kit comprising the nucleic acid; further provided is a fusion protein of the prepared truncated form of TGFβR2 receptor protein and a targeted EGFR and other multiple types of tumor target antibodies.
Patent AU-2021269764-A1 (AU)
Title: ATR inhibitors for the treatment of cancer
Inventor: SMITH SIMON ANDREW
IPC: A61K45/06
Filed: 2021-05-10
Abstract: This specification discloses the use of an ATR inhibitor, preferably in combination with a taxane, for the treatment of cancer in a particular subset of patients who have previously received immunotherapy.
Patent AU-2021273813-A1 (AU)
Title: Methods and compositions for treating stroke
Inventor: WANG YONGTING
IPC: G01N33/53
Filed: 2021-05-19
Abstract: Compositions and methods for treating stroke in a mammalian subject are provided. The compositions and methods generally entail administration of an effective amount of a growth and differentiation factor 11 (GDF11) molecule to a subject initiating within a short time window after a stroke event, wherein the GDF11 molecule is administered at a high dose relative to the body weight of the subject and such administration regimen is carried out over a short period of time ranging from 1 to about 14 days.
Patent AU-2021274879-A1 (AU)
Title: Maxi-K potassium channel openers for the treatment of fragile X associated disorders
Inventor: FLECK ROMAN
IPC: A61P13/10
Filed: 2021-05-20
Abstract: The present invention relates to the compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds provided herein can act as maxi-K potassium channel openers, which makes them suitable for use in therapy, particularly in the treatment or prevention of fragile X associated disorders, such as fragile X syndrome.
Patent AU-2021275656-A1 (AU)
Title: Circular parallel plate grit remover
Inventor: DEJU LILUNNAHAR
IPC: C02F1/38
Filed: 2021-04-06
Abstract: A grit removal unit including a cylindrical grit removal chamber above a grit storage chamber, with an opening to the grit storage chamber through the grit removal chamber bottom. At least one layer plate is an inverted truncated cone around the center axis which is spaced from the grit removal chamber vertical wall to allow fluid flow therebetween. Concentric inverted truncated cone lamella plates are supported in the grit removal chamber above the layered plates, with the lamella plates radially spaced from one another relative to the center axis. An influent opening in the grit removal chamber vertical wall below the layered plates allows fluid and grit into the grit removal chamber, and an effluent opening in the grit removal chamber vertical wall above the lamella plates allows fluid to exit the grit removal chamber.
Patent AU-2021281219-A1 (AU)
Title: Anchoring strain relief member
Inventor: BEAN RYAN MCNALLY
IPC: A61M39/06
Filed: 2021-05-26
Abstract: An anchor strain relief member provides resistance to disengagement from a hemostatic valve due to forces tending to force the catheter in a proximal direction. The anchoring strain relief member is distal to a hub, joined to the catheter outer surface, and comprises a sealing portion that has at least one ridge that has a ridge tip and a ridge height defined by a distance from the ridge tip to the catheter central axis. Methods of forming a nested catheter system are described using a catheter with an anchor strain relief as the inner catheter for the nested catheter set. Systems of a hemostatic valve and a suitable catheter with an anchor strain relief member can provide for desired assemblies of components.
Patent AU-2021290359-A1 (AU)
Title: An improved metal detector
Inventor: CANDY BRUCE HALCRO
IPC: G01V3/10
Filed: 2021-12-23
Abstract: A method for detecting a metal target in soil using a metal detector comprising the steps of: 
generating a transmit magnetic field for transmission into the soil using a transmit winding based on a 
transmit signal; receiving a first receive magnetic field using the transmit winding during a receive 
period to produce a first receive signal; receiving a second receive magnetic field using a receive 
winding during the receive period to produce a second receive signal, wherein the transmit winding 
and the receive winding are separated spatially; and producing an indicator output signal based on the 
first receive signal, the second receive signal and at least one synchronous demodulation function; 
wherein the first receive signal includes first parameters that define a first transfer function 
transforming the first receive magnetic field into the first receive signal, the first parameters including 
an effective number of turns, a geometry of the transmit winding, and first electronic amplification 
transfer functions between the transmit winding and first receive signal; wherein the second receive 
signal includes second parameters that define a second transfer function transforming the second 
receive magnetic field into the second receive signal, the second parameters including an effective 
number of turns, a geometry and a relative orientation of the receive winding with respect to the 
transmit winding, and second electronic amplification transfer functions between the receive winding 
and second receive signal; wherein the first parameters and the second parameters are selected such 
that the first receive signal and the second receive signal are processed together to reduce or null 
detected signals within the indicator output signal due to received soil eddy currents from conducting 
soil components manifested in the first receive signal and the second receive signal; and wherein the 
selection of the first parameters relative to the second parameters are dependent on the synchronous 
demodulation function.  
1 1 
G2 
15 
R~ R1 RFt
3/3 
C 
0 
C.) 
C 
C 
C~ Cl) 
-~ U) U) 
o > E 
C 
(~ C~) o 
V 
w 0 
.C .C V 
U) 
0 
S.
0~ 
E 
0 
S.
U) 
U) 
* .5 ~Iqm C 
V 
U) C 
0 
H S.~ Li.  
0 
Cl) 
U) 
_ C 
C~) 
V 
C C 
0 0 o 0 U) 
U) 
V 
U) 
L..  
U) 
0 
.0 
0 
* 
~suods~>j
Patent AU-2021296222-A1 (AU)
Title: Plug with composite ends and method of forming and using
Inventor: CARRAGHER PAUL
IPC: E21B33/13
Filed: 2021-06-22
Abstract: A plug with composite reinforced end(s) and a mostly-bismuth-alloy middle section. At least one end comprises a composite material. One end is a composite, with a bismuth alloy and a particulate material of greater strength than the bismuth material. A plug having both ends of the composite material.
Patent AU-2021299422-A1 (AU)
Title: Catheter tip passive control device and related systems and methods
Inventor: STALEY SHAUN
IPC: A61M25/09
Filed: 2021-06-14
Abstract: A vascular access device to passively open a fluid path within a vasculature. The vascular access device may include a catheter and a guidewire. The catheter may have a proximal end, a tip, and a length of tubing therebetween. The guidewire may extend along the length of tubing and may include a bent portion. At least a portion of the length of tubing may substantially conform to the bent portion such that the tip of the catheter avoids an obstruction within the vasculature.
Patent AU-2021299570-A1 (AU)
Title: Pharmaceutical compositions of 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid and ester derivatives thereof
Inventor: PEARSON JAMES PHILIP
IPC: A61K31/4709
Filed: 2021-07-02
Abstract: 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid and 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid hydrocarbyl ester derivatives of formula are disclosed, as are pharmaceutical compositions and methods for the treatment of pain, epilepsy, convulsions, and seizures employing those compositions.
Patent AU-2021300435-A1 (AU)
Title: Handle for a personal care implement and personal care implement
Inventor: HALLEIN CHRISTINE
IPC: B25G1/10
Filed: 2021-07-02
Abstract: A handle for a personal care implement has a longitudinal extension extending between a distal end and a proximal end, the proximal end being opposite the distal end and closest to a head permanently or releasably attached to the handle. The handle has an outer lateral surface with a three-dimensional surface structure, wherein the surface structure comprises at least two continuous wave bands with alternating convex and concave curvatures forming wave crests and wave troughs, respectively, the wave bands extending along the longitudinal extension of the handle.
Patent AU-2021337890-A1 (AU)
Title: Work machine, system and method for controlling work machine
Inventor: KADONO YUUICHI
IPC: E02F3/85
Filed: 2021-07-07
Abstract: A first process is to acquire a travel state of a first work machine that is performing work using a work device while traveling on a first work route. A second process is to determine whether the first work machine is deviating from the first work route on the basis of the travel state. A third process is to stop the travel of the first work machine when it is determined that the first work machine is deviating from the first work route.
Patent AU-2021379667-A1 (AU)
Title: Method of iron electrode manufacture and articles and systems therefrom
Inventor: GIBSON MICHAEL ANDREW
IPC: H01M4/02
Filed: 2021-11-10
Abstract: Iron electrode materials, iron electrodes, and methods for fabricating said iron electrode materials and iron electrodes via elevated temperature thermomechanical processing of porous particulate iron materials are described. For example, as part of iron electrode manufacture, a particulate iron material into an apparatus may be provided. In addition, pressure and/or heat may be applied to the particulate iron material in the apparatus for a time period to form an electrode having therein conductive connections between particles of the particulate iron material.
Patent AU-2021397214-A1 (AU)
Title: Methods and compositions comprising a krasg12c inhibitor and a egfr-inhibitor for treating solid tumors
Inventor: EVANGELISTA MARIE
IPC: A61K31/506
Filed: 2021-12-06
Abstract: Provided herein are combination therapies comprising a KRas
Patent AU-2021403021-A1 (AU)
Title: Systems and methods for identifying cancer in pets
Inventor: PARKINSON MARK
IPC: G06N3/045
Filed: 2021-12-15
Abstract: In one embodiment, the disclosure provides a method comprising: receiving an image of a biopsy slide; executing first programmed instructions to input the image to a first trained machine learning model programmed as a cancer classifier, thereby outputting a classification; determining, based on the classification, that the image should be further processed; executing a tissue detect ion algorithm on the image of the biopsy slide, thereby outputting a first set of coordinates; executing second programmed instructions to input the image of the biopsy slide and the first set of coordinates to a second trained machine learning model programmed for image segmentation, thereby outputting a binary pixel mask; executing third programmed instructions to generate an enhanced pixel mask using the binary pixel mask; and digitally storing, in computer memory, a second set of coordinates indicated by the enhanced pixel mask, in one embodiment, a 10-high-power field can be generated and digitally stored.
Patent WO-2023064977-A1 (WO)
Title: Procédé et installation d'adsorption modulée en pression sous vide pour la production de dioxyde de carbone pur à partir de gaz de dégagement industriel contenant du co 2
Inventor: XIAO PENNY Y
IPC: B01D53/047
Filed: 2022-10-16
Abstract: L'invention concerne un procédé d'adsorption modulée en pression sous vide et une installation à colonnes multiples pour séparer le dioxyde de carbone (CO2) d'un gaz de dégagement industriel contenant du CO2 à basse pression et le purifier à 99 % de CO2 en volume. L'adsorption modulée en pression sous Vide (VPSA) comprend une étape d'alimentation, deux ou trois ensembles d'étapes d'égalisation de pression, une étape de purge de gaz de produit CO2, une étape de désorption et une étape de re-pressurisation de gaz d'alimentation. L'installation pour mettre en œuvre ledit procédé VPSA comprend cinq colonnes d'adsorption parallèles ou plus, six vannes de commande d'électrovannes pour chaque colonne, et un réservoir de stockage, une pompe à vide de gaz de produit CO2 et un réservoir de stockage, un ventilateur/compresseur de purge de gaz CO2 et un réservoir de stockage, un réservoir de stockage de gaz pauvre en CO2, et des tuyaux correspondants reliant les vannes, les réservoirs et les dispositifs rotatifs aux colonnes d'adsorption.
Patent AU-2022200055-A1 (AU)
Title: Improved systems and methods for sharing physical writing actions
Inventor: KOLAHDOUZAN VAHID
IPC: G06F3/048
Filed: 2022-01-06
Abstract: IMPROVED SYSTEMS AND METHODS FOR SHARING PHYSICAL WRITING ACTIONS 
A server and computer implemented method for sharing physical writing actions, the method 
comprising the steps of: detecting, at each of a plurality of computing devices associated with a 
meeting, one or more physical writing actions being performed on physical writing surfaces; 
generating writing signals based on the physical writing actions; transmitting the generated 
writing signals to a server; forwarding, via the server, the writing signals for receipt at the 
plurality of computing devices associated with the meeting; and each computing device 
outputting a representation of the physical writing actions.
Patent AU-2022200492-A1 (AU)
Title: Methods of inducing anesthesia
Inventor: BROSNAN ROBERT J
IPC: A61K31/015
Filed: 2022-01-27
Abstract: The present invention provides methods for determining the selectivity of an anesthetic for 
an anesthetic-sensitive receptor by determining the molar water solubility of the anesthetic.  
The invention further provides methods for modulating the selectivity of an anesthetic for an 
anesthetic-sensitive receptor by altering or modifying the anesthetic to have higher or lower 
water solubility. The invention further provides methods of inducing anesthesia in a subject 
by administering via the respiratory pathways (e.g., via inhalational or pulmonary delivery) an 
effective amount of an anesthetic compound identified according to the present methods.
Patent AU-2022202522-A1 (AU)
Title: Peptides And Combination Of Peptides Of Non-Canonical Origin For Use In Immunotherapy Against Different Types Of Cancer
Inventor: SCHUSTER HEIKO
IPC: C07K7/06
Filed: 2022-04-14
Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in 
immunotherapeutic methods. In particular, the present invention relates to the 
immunotherapy of cancer. The present invention furthermore relates to tumor
associated T-cell peptide epitopes, alone or in combination with other tumor-associated 
peptides that can for example serve as active pharmaceutical ingredients of vaccine 
compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo 
and transfer into patients. Peptides bound to molecules of the major histocompatibility 
complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell 
receptors, and other binding molecules.